Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TECVAYLI® (teclistamab-cqyv)

Medical Information

+ Save link

TECVAYLI - Preparation and Administration Using Aseptic Technique in Clinical Trials

Last Updated: 08/16/2024

SUMMARY

Aseptic technique should be used to prepare and administer TECVAYLI.¹
In clinical trials, TECVAYLI was prepared using aseptic technique. It was preferred that the preparation of the product be performed under a laminar flow hood or biosafety cabinet.²

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File databases (and/or other resources, including internal/external databases) was conducted on 08 August 2024.

References

Show

1	Data on File. Teclistamab. Company Core Data Sheet. Janssen Research & Development, LLC. EDMS-RIM-378072; version 007; 2024.
2	Data on File. Investigational Product Preparation and Administration Instructions for Subcutaneous Administration of 10 mg/mL and 90 mg/mL Teclistamab (JNJ-64007957) by Weight Based Dosing in mg/kg. TV-TEC-208759; version 5.0; 2023.